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Introduction
"We have arrived at that brave new world that seemed so distant in
1932, when Aldous Huxley wrote about human beings created in test
tubes,"1 remarked President Bush as he announced new restrictions on
federal funding of stem cell research. 2 Embryonic stem cells are a unique
class of cells that possesses the ability to differentiate into almost all of the
cells and tissues of the human body. 3 Scientists believe that stem cell
research will enable them to find cures for many debilitating diseases.
They envision a system of medicine where an Alzheimer's patient could
regain his memory by replenishing his brain cells, or a person with kidney
4
failure could revive her organs with new cells rather than a transplant.
Scientists believe that this is the untapped power of the stem cell: the ability for patients to draw on their own body's cells and customize stem cells
to heal their ailments. 5 According to Dr. Harold Varmus, former Director
of the National Institutes of Health (NIH), "there is almost no realm of
medicine that might not be touched by this innovation ....

It is not too

unrealistic to say that this research has the potential to revolutionize the
practice of medicine and improve the quality and length of life. ' 6 Scientists involved with embryonic stem cell research say that they cannot ignore
any research avenues because they do not know which cells work best as
7
research mediums for particular diseases.
The legal history surrounding stem cell research demonstrates the
U.S. federal government's reluctance to embrace this research. In 1994, the
NIH's Embryo Research Panel recommended the use of federal funds to
support research using human embryos.8 Congress did not agree with the
recommendation, and enacted a federal law banning the use of appropriated federal funds for any research "in which a human embryo or embryos
are destroyed, discarded, or knowingly subjected to risk of injury . . .
greater than that allowed for research on fetuses in utero." 9 The Depart1. Address to the Nation on Stem Cell Research, 2
2001) [hereinafter Bush Address].
2. Id.

3. See

NAT'L

INSTS.

OF

HEALTH,

STEM

CELL

PUB. PAPERS

BASICS

953, 955 (Aug. 9,

(2002),

at http://

stemcells.nih.gov/infoCenter/StemCellBasics.asp (last visited Nov. 15, 2003) [hereinafter STEM CELL BASICS].
4.

See 1

NAT'L BIOETHICS ADVISORY COMM'N, ETHICAL ISSUES IN HUMAN

STEM CELL

(1999), available at http://bioethics.georgetown.edu/nbac/stemcell.pdf [hereinafter NBAC REPORT].
5. See NAT'L INSTS. OF HEALTH, STEM CELLS: SCIENTIFIC PROGRESS AND FUTURE
RESEARCH

ES-1 (2001), http://stemcells.nih.gov/stemcell/scireport.asp (last
visited Oct. 4, 2003) [hereinafter NIH EXEC. SUMMARY].
RESEARCH DIRECTIONS

6. Stem Cell Research: Hearings Before the Subcomm. on Labor, Health & Human
Servs., Educ., & Related Agencies of the Senate Comm. on Appropriations, 105th Cong. 910 (1998) (statement of Harold Varmus, M.D., Director, National Institutes of Health).
7. See Nat'l lnsts. of Health Guidelines for Research Using Human Pluripotent Stem
Cells, 65 Fed. Reg. 51,976, 51,976 (Aug. 25, 2000) (corrected at 65 Fed. Reg. 69,951
(Nov. 21, 2000)) available at http://nih.gov/news/stemcell/stem/cellguidelines.htm.
8. See NBAC REPORT, supra note 4, at 43, n.55.
9. Omnibus Consolidated and Emergency Supplemental Appropriations Act of
1999, Pub. L. No. 105-277, § 511(a), 112 Stat. 2681-386. The Act defined human
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ment of Health and Human Services (DHHS) reinterpreted the statute's
language in 1999 to find that it did not apply to stem cells. '0 DHHS relied
upon the statute's definition of embryos as "organisms," deciding that stem
cells are not organisms and thus not embryos with respect to the law."
Concurrently, advances in the field of stem cell research 12 led to
increased debate as to whether such research was ethical. 13 The primary
ethical concern was the source of stem cells.' 4 Prior to 1998, scientists
had used only animal embryos for embryonic stem cell research. But in
1998, Dr. James Thompson of the University of Wisconsin and Dr. John
Gearhart of Johns Hopkins University each used privately funded laboratories to isolate and culture human embryonic stem cells for research.1 5 An
ethical issue with using human stem cells arises because an embryo used
for the sake of its stem cell tissue cannot develop to term, and is thereby
denied the opportunity to become a human being.' 6 Thus, the argument
goes, the potential of the embryo to become a human is devalued in favor
7
of its immediate value as a source of tissue.'
In response to these initial debates, President Clinton requested that
the National Bioethics Advisory Committee (NBAC) review the ethical
issues of stem cell research.' 8 The NBAC concluded that it was ethically
permissible for the federal government to support research using stem cells
embryo as "any organism, not protected as a human subject under 45 CFR 46 as of the
date of the enactment of this Act, that is derived by fertilization, parthenogenesis, cloning, or any other means from one or more human gametes or human diploid cells." Id.
§ 51 l(b); see also EllenJ. Flannery & Gail H. Javitt, Analysis of FederalLaws Pertainingto
Funding of Human PluripotentStem Cell Research, in 2 NAT'i BIOETHICS ADVISORY COMM'N,
ETHICAL ISSUES IN HUMAN STEM CELl RESEARCH

D-6 (2000).

10. See Flannery & Javitt, supra note 9, at D-7, D-8.
11. Memorandum from Harriet S. Rabb, General Counsel, Department of Health
and Human Services, to Harold Varmus, M.D., Director, National Institutes of Health on
Federal Funding for Research Involving Human Pluripotent Stem Cells (Jan. 15, 1999),
reprinted in Lori B. Andrews et al., GENETICS: ETHICS, LAW AND POLICY 131, 138 (2002).
12. First, John Gearhart and his colleagues at Johns Hopkins University School of
Medicine succeeded in isolating embryonic germ cells from the discarded fetal tissue of
an elective abortion. See MJ. Shamblott et al., Derivation of Pluripotent Stem Cells from
Cultured Human PrimordialGerm Cells, 95 PROC. OF THE NAT'L ACADEMY OF SCI 13,726
(1998). James Thompson and his colleagues at the University of Wisconsin derived
stem cells from a surplus embryo donated by a couple who underwent infertility treatment. See James A. Thompson et al., Embryonic Stem Cell Lines Derived from Human
Blastocysts, 282 Sci. 1145 (1998). Later, researchers funded by Advanced Cell Technology claimed that using somatic cell nuclear transfer they created a hybrid embryo of
human somatic cells and cow eggs and thereafter isolated human embryonic stem cells.
See Nicholas Wade, Researchers Claim Embyronic Cell Mix of Human and Cow, N.Y.
TIMES, Nov. 12, 1998, at Al.
13. See NBAC REPORT, supra note 4, at 7.
14. See Ted Agres, On the Brink: A Pending Government Decision Keeps Stem Cell
Investigators in Limbo, THE SCIENTIST, May 28, 2001, available at http://www.the-scientist.com/yr2001/may/agres-p l_010528.html.
15.

See NAT'L INSTS. OF HEALTH, NIH FACT SHEET ON HUMAN PLURIPOTENT STEM CELL

RESEARCH GUIDELINES (2001), at http://www.nih.gov/news/stemcell/stemfactsheet.htm.
16. See Bush Address, supra note 1, at 955.
17. See id.
18. See NBAC REPORT, supra note 4, at i.
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from (1) embryos left over from fertility treatments,' 9 and (2) cadaveric
fetal tissue from elective abortions. 20 Soon after, the NIH published guidelines to regulate stem cell research that supported the NBAC's conclusion. 2 1 Bearing in mind that Congress had rejected its 1994
recommendation to use federal funds for research purposes, the NIH distinguished embryonic stem cells derived for research purposes and those
used for research purposes. 22 The NIH guidelines prohibited publicly
funded scientists from employing the former type of stem cells.23
The NIH guidelines were never fully implemented because President
George W. Bush placed a moratorium on stem cell research soon after taking office. 24 Then, on August 9, 2001, President Bush announced federal

mandates that restricted the funding of stem cell research such that
researchers could only use embryonic stem cell lines created prior to the
announcement of the mandates. 25 The NIH determined that sixty-four
human embryonic stem cell lines existed at the time of the
26
announcement.
Despite numerous complaints from the scientific community, 27 these
28
mandates remain in effect. The mandates have increased research delays
19. See id. at iii.
20. See id. at iv.
21. See Nat'l lnsts. of Health Guidelines for Research Using Human Pluripotent Stem
Cells, 65 Fed. Reg. at 51, 976.
22. See id.
23. See id. at 51, 977.
24. See Morton M. Kondracke, Bush Wisely Orders HHS Study of Fetal, Stem Cell
Issues, ROLL CALL, Feb. 1, 2001, at 6.
25. See Bush Address, supra note 1, at 957; see also Carter M. Yang et al., Stem Cell
Compromise:Bush Backs Limited Research, ABC NEWS (Aug. 10, 2001) available at http://
www.abcnews.go.com/sections/politics/DailyNews/stemcells-BushO 10809.html
(recounting President Bush's decision on federal funding for stem cell research).

26. See

NAT'L INSTS. OF HEALTH, UPDATE ON EXISTING HUMAN EMBRYONIC STEM CELLS

(2001) at http://www.nih.gov/news/stemcell/082701list.htm.
27. See Status of the Implementation of the Federal Stem Cell Research Policy: Hearings
Before the Subcomm. on Labor, Health & Human Servs., Educ., & Related Agencies of the
Senate Comm. on Appropriations, 107th Cong. 20 (2002) (statement of Curt 1. Civin,
M.D., professor, John Hopkins University), available at 2002 WL 100237571 [hereinafter Statement of Curt I. Civin] (stating that his research has been stunted by President
Bush's mandate that only the sixty-four existing stem cell lines could be used for federally funded research because "none of these cell lines was available readily to us[,]" and
noting that "embyronic stem cell research is crawling like a caterpillar" in the United
States). See also Scientists: Stem Cell Rules Halt Progress, Oct. 2, 2002, at http://
cnn.health.com (noting that the federal rules governing the use of embryonic stem cells
in research has delayed advances in medical research); see also Yang, supra note 25
(quoting U.S. Senator Tom Daschle stating that there is "concern about the limits the
[P]resident has proposed on this research, specifically that the existent stem cell lines
could be inadequate to realize its potential lifesaving benefits.").
28. See Statement of Curt I. Civin, supra note 27, at 21. Dr. George Daley of the
Whitehead Institute at Massachusetts Institute of Technology stated that "the existing
restrictions are keeping advances from being realized" and noted that far fewer cell lines
are available than the number previously cited by the Bush administration. See Status of
the Implementation of the Federal Stem Cell Research Policy: Hearings Before the Subcomm.
on Labor, Health & Human Servs., Educ., & Related Agencies of the Senate Comm. on
Appropriations, 107th Cong. 26 (2002). For example, Dr. Curt Civin of Johns Hopkins
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and brain drain 29 in the United States. Many scientists fear that the limits

on federal funding severely constrain their research abilities by making
access to adequate stem cell lines a slow and frustrating process. 30 Others
have moved, or plan to move, their research to countries with less restric31
tive regulations on stem cell research.
This Note argues that the federal mandates restricting stem cell
research inappropriately handle the ethical considerations of stem cell
research by (1) reflecting the Bush administration's conservative views and
pro-life beliefs, and (2) failing to consider both the social costs, such as the
delay to current research, the sacrifice of medical advances, and the inevitable "brain drain" from the United States caused by these impediments,
and the social benefits of stem cell research. Noting the influx of stem cell
researchers to Singapore, where there are more liberal research laws, 32 I
will propose that the United States should adopt an approach for federallyfunded embryonic stem cell research like that of Singapore, which is more
global and progressive, but still closely regulates research boundaries.
Part I of this Note briefly summarizes stem cell biology and research
use. Part II discusses the current state of stem cell research in the United
States. Part III details Singapore's regulatory scheme for stem cell research.
Part IV compares the U.S. and Singaporean approaches to the ethical considerations of stem cell research. Part V discusses the shortcomings of the
Bush administration's mandates and the need to adopt an approach like
that of Singapore, which incorporates ethical concerns into an analysis of
the costs and benefits of stem cell research.
I. Stem Cells
Any given human being is never the same conglomerate of cells on a
day-to-day basis but nevertheless remains the same person. This may seem
University negotiated for months with the owners of cell lines in India only to have the
Indian government ban the export of the cells. See Statement of Curt I. Civin, supra note

27, at 21. Roger Pendersen, who formerly worked at the University of California, San
Francisco, but moved to Cambridge University in England to take advantage of more

liberal stem cell research regulations, noted that the lack of U.S. federal support has

"undoubtedly" delayed the benefits of research to patients with degenerative diseases.
Status of the Implementation of the Federal Stem Cell Research Policy: Hearings Before the
Subcomm. on Labor, Health & Human Servs., Educ., & Related Agencies of the Senate
Comm. on Appropriations, 107th Cong. 12 (2002).
29. See Send in the Clones, THE EcONOMIST, Aug. 24, 2002, at 58. (discussing the
recent influx to researchers to Singapore to take advantage of new research facilities,
large amounts of funding, and permissive stem cell research regulations).
30. See Statement of Curt I. Civin, supra note 27, at 20; see also Melissa Huang, Stem
Cells Responsible for Medical Discoveries, Ethics Controversy, UNIVERSITY WIRE, Sept. 17,
2001 (quoting Ted Kennedy as stating that "many in the scientific community are concerned that the President's decision will delay development of cures for dread disease
for many years, at the cost of countless lives and immeasurable suffering"); Kelly Hearn
New Stem Cell Lines Will be Needed, UNITED PRESS INT'L, Oct. 31, 2001 (expressing concern that "existing stem cell lines could accrue genetic abnormalities over time[,j" thus
requiring new stem cell lines).
31. See Statement of Curt I. Civin, supra note 27, at 22.
32. See id.; see also infra note 80.
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like an odd statement, at least until one considers that human beings are
made up of trillions of cells which are constantly being replenished or
repaired by other cells: stem cells. While most of the body's cells are
organized into specialized tissues and organs, stem cells are unspecialized
33
and have the potential to become different cell types.
There are two main types of stem cells: adult and embryonic. Adult
stem cells are specific to certain tissues-usually bone marrow, skin, liver,
and other organs-and have the limited ability to form certain cell types for
only their assigned tissue. 3 4 Embryonic stem cells can form virtually any
cell in the body, because unlike adult stem cells, they are not differentiated
35
for a specific tissue.
Embryonic stem cells are unique in that they are self-renewing and can
repopulate themselves while in an undifferentiated state. 36 In contrast,
adult stem cells are specialized and cannot maintain long-term, selfrenewing capacities. 3 7 The ability of embryonic stem cells to divide extensively has led some nonscientists to assert that researchers can simply use
existing stem cell lines for their research. 38 However, many scientists, and
39
the NBAC, state that this is a misunderstanding of the science involved.
They say that it is essential for scientists to repeatedly derive new embryonic stem cell lines because (1) the properties of the cells differ depending
on the methods used to derive them, (2) embryonic stem cells are unstable
cell types that cannot undergo mass production without sustaining irreversible changes, 40 and (3) there remains a tremendous amount for scien33. See NBAC REPORT, supra note 4, at 1.
34. See Ariff Bongso, M.D., Human Embryonic Stem Cells- Science & Ethics, in ETHICAL, LEGAL AND SOCIAL ISSUES IN HUMAN STEM CELL RESEARCH, REPRODUCTIVE AND THERA-

PEUTIC CLONING: A REPORT FROM THE BIOETHICS ADVISORY COMMITTEE SINGAPORE E3-6, E37 (2002); STEM CELL BASICS, supra note 3. Recent research has shown, however, that

some adult stem cells, when transferred to another tissue, take on the characteristics of
that tissue. See Juan R. Sanchez-Ramos et al., Expression of Neural Markers in Human
Umbilical Cord Blood, 171 EXPERIMENTAL NEUROLOGY 109 (2001) (bone marrow cells to
muscle cells and to nerve cells); A.L. Vescovi, R. Galli & A. Gritti, The Neural Stem Cells
and Their Transdifferentiation Capacity, 55 BIOMEDICINE & PHARMACOTHERAPY 201, 203
(2001) (the reverse); Vaclav Ourednik et al., Segregation of Human Neural Stem Cells in
the Developing Primate Forebrain,293 ScI. 1820 (2001) (glial cells to nerve cells); Christopher R.R. Bjornson et al., Turning Brain into Blood: A Hematopoietic Fate Adopted by
Adult Neural Stem Cells in Vivo, 283 ScI. 534 (1999) (neural stem cells to blood cells).
35. See STEM CELL BASICS, supra note 3.
36. See id.
37. See id.
38. See NBAC REPORT, supra note 4, at 19. It is President Bush's view that the stem
cell lines existing as of August 9, 2001 are sufficient to sustain stem cell research in the
United States. See Bush Address, supra note 1, at 955-56.
39. See NBAC REPORT, supra note 4, at 19.
40. A study showed that existing stem cell lines commonly used by researchers have
lost the ability to generate all mouse tissues. See A. Nagy et al., Derivation of Completely
Cell Culture-Derived Mice from Early-Passage Embryonic Stem Cells, 90 PROCEEDINGS OF
THE NAT'L ACADEMY OF SCIS. USA, 8424 (1993). The researchers concluded, "[P]rolonged
passage in culture reduces the potential of the ES-cell population as a whole . .. [T]he
proportion of cells that retains full potential diminishes with extended passage." Id. at
8427.
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tists to learn about the derivation process. 4 1
Embryonic stem cells can be derived from four main sources: (1)
human fetal tissue following an elective abortion (also called cadaveric tissue); (2) human embryos created by in vitro fertilization (as a fertility treatment) that are in excess of fertility need and are voluntarily donated; (3)
human embryos created by in vitro fertilization where the sperm and eggs
are donated for the sole purpose of providing research material; and (4)
human embryos created asexually by a technique called 'somatic cell
nuclear transfer,' which moves an adult human cell nucleus into an enucle42
ated human egg (also called therapeutic cloning).
Scientists believe that human embryonic stem cells will revolutionize
the treatment of many debilitating diseases. Today, doctors often use
donated tissues and organs to replace destroyed or ailing tissue, but the
need for tissues and organs far outweighs supply. 4 3 Stem cells offer a possible renewable source of replacement cells and tissues to treat many diseases. 44 Two factors contribute to these great therapeutic expectations: (1)
the ability of embryonic stem cells to produce almost unlimited numbers of
any cell in the body, and (2) the possibility that embryonic stem cells may
be genetically engineered to prevent immune rejection by transplant recipients.45 Potential treatments include replacing insulin-producing cells in
children with Type 1 diabetes, 4 6 replacing dopamine-producing cells in
individuals with Parkinson's disease, 4 7 correcting diseases of the bone or
cartilage, such as osteogenesis, 48 replacing tissue damaged by radiation or
chemotherapy cancer treatments, 4 9 and restoring immunity in people with
AIDS. 5 0

Clinical treatments would involve direct injection of the embry-

onic stem cells into the diseased sites.5 1 It is conceivable that doctors
52
could use embryonic stem cells to build new organs for transplantation.
41. See NBAC REPORT, supra note 4, at 20.
42. See id. at 1-2; Bongso, supra note 34, at E3-2.

43. See

STEM CELl BASICS,

supra note 3.

44. See Press Release, Fact Sheet: Embryonic Stem Cell Research (August 9, 2001),
available at http://www.whitehouse.gov/news/releases/2001/08/print/20010809I .html.
45. See Bongso, supra note 34, at E3-5.
46. See Suheir Assady et al., Insulin Production by Human Embryonic Stem Cells, 50
DIABETES 1691 (2001).
47. See Evelyn Strausss, Stem Cells Make Brain Cells, in American Assoc. for the
Advancement of Science: Globe-Girdling Science in the Golden Gate City, 291 Sci. 1689,
1689-90 (2001).
48. See Barbara A. Huibregtse et al., Effect of Age and Sampling Site on the ChondroOsteogenic Potential of Rabbit Marrow-derived Mesenchymal Progenitor Cells, 18 J.
ORTHOPAEDIC RESEARCH 18, 18-24 (2000).
49. See Rita C. R. Perlingeiro, Michael Kyba & George Q. Daley, Clonal Analysis of
Differentiating Embryonic Stem Cells Reveals a Hematopoietic Progenitor with Primitive

Erythroid and Adult Lymphoid-Myeloid Potential, 128
(2001).

DEVELOPMENT

4597, 4597-4604

50. See Rafael G. Amado, Ronald T. Mitsuyasu & Jerome A. Zack, Gene Therapy for
the Treatment of AIDS: Animal Models and Human Clinical Experience, 4 FRONTIERS BiosCIENCE

d468, d468-75 (1999).

51. See Bongso, supra note 34, at E3-6.
52. See id.
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Status of Stem Cell Research in the United States
"As the discoveries of modern science create tremendous hope, they also lay vast
ethical mine fields. As the genius of science extends the horizons of what we can
do, we increasingly confront complex questions about what we should do ....
So I have decided we must proceed with great care. "53

In 2001, President Bush stated that the federal government would not
endorse or fund stem cell research that would result in further destruction
of human embryos.5 4 As a result, scientists could either try to use one of
the validated, existing stem cell lines, or establish two separate laboratories: one for federally-funded stem cell research and the one for privatelyfunded stem cell research. 55 Most scientists find the latter route unfeasible
because it creates duplication that is incredibly expensive 5 6 and private
funding sources have significantly decreased due to changes in the
57
economy.
On the other hand, scientists who chose the former route complain
that more than a year later, they still have not been able to locate or obtain
viable stem cell lines to use for their research. 58 They note that the
problems hindering their ability to obtain cell lines include questions of
who owns the line, scientists not wanting to share their lines with other
researchers, companies demanding a piece of profits of future discoveries
in exchange for cell lines, and the astronomical fees charged to obtain
lines. 5 9 Additionally, because little is known about the cell lines themselves, scientists must engage in time-consuming and frustrating processes
60
to determine whether a particular cell line will advance their research.
While the NIH has listed more eligible lines on its registry, 6 1 only a fraction of these lines are accessible, and scientists are wary of the persistence
62
and patience needed to obtain the cell lines.

53. Bush Address, supra note 1, at 955 (emphasis added).
54. Laura Abel, Drawing Lines for Dollars, LEGAL TIMES, Sept. 30, 2002, at 62.
55. See id.
56. See id. (noting the added costs of obtaining two, rather than one, set of laboratory equipment and the time for scientists to commute between labs).
57. See Statement of Curt I. Civin, supra note 27, at 21.
58. See id. at 20. (noting that while the NIH provided a list of stem cell lines that
could be used in federally funded research, scientists quickly discovered that "none of
these cell lines was available readily to us"). Dr. Civin states that he spent several
months negotiating with an Indian company, Reliance Life Sciences, to obtain cell lines
that, as required by his research needs, would not form blood cells and would grow
rapidly. See id. at 21. The agreement was cancelled, however, in May 2002 when the
Indian government put an indefinite hold on the export of stem cells. See id. Additionally, he recounts the story of a colleague who applied to receive a line of stem cells from
Wisconsin in the Fall of 2001. See id. After a series of negotiations, a $5,000 fee, and a
six-month wait, his colleague finally received the cells, only to discover that they grow
exceedingly slowly-at one-tenth the rate of cells normally used. See id.
59. See id. (stating that the administrative burdens to obtain a cell line are unreasonable and that while researchers used to pay $50-100 for a cell line, they now have to pay
$5,000 upfront).
60. See id.
61. See Scientists: Stem Cell Rules Halt Progress, supra note 27.
62. See id.
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U.S. scientists are understandably frustrated with the slow pace the
new regulations have forced them to assume. 6 3 There is a broader concern
that the United States, traditionally a leader in biomedical research, is falling behind 64 and that the American people, who are usually the first in line
65
for new medical treatments, will have to wait longer.
While most Americans believe that human stem cell research should
continue, 6 6 they probably do not realize that stem cell research is continuing at a much faster pace in other countries. Americans are also probably
unaware that the "brain drain" caused by the outflow of U.S. scientists to
other countries is a growing problem. 6 7 Lured by the prospect of readily
available stem cell lines that adequately fit their research needs and more
favorable regulations of stem cell research that allow for a wider pool from
which to select stem cells, leading U.S. stem cell researchers are moving
68
their laboratories to other countries.
However, not all American states are content to watch as stem cell
researchers struggle. 69 On September 22, 2002, then Governor Gray Davis
of California signed legislation 70 that overrides the federal stem cell man63. See statement of Curt I. Civin, supra note 27, at 22 (stating that "without our
vigorous leadership in federally supported stem cell research, the pace of discoveries will
be much slower than necessary.").
64. See id. (noting that "exciting new stem cell research" has been reported by China,
Singapore, Australia, and the U.K.).
65. See id.
66. In a June 2001 poll conducted by ABC and Beliefnet.com, 58% of Americans
supported federal funding of embryonic stem cell research, while only 30% opposed it.
See Deborah Caldwell, The Surprising Politics of Stem Cells, Aug. 5, 2001, available at
http://www.beliefnet.com/story/82/story_8276 1.html.
67. England faced a similar issue when prior to parliamentary approval of stem cell
research, scientists noted that absent this approval they would leave the country to
research abroad where stem cell research regulations were more lenient. See Melissa
Kite, MPs Pressured Over Human Embryo Vote, THE TIMES (London), December 19, 2000,
at 8.
68. See Statement of Curt 1. Civin, supra note 27, at 22; see infra note 76.
69. Authorization to conduct research on human embryos has been left to the discretion of the states, subject to the approval of the U.S. Food and Drug Administration
under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act. See
Dep't. of Health and Human Services Protection of Human Subjects, 45 C.F.R. § 46

(2000).
70. See CAL. HEALTH & SAFETY CODE §§ 125115-125117 (2003). The Code reads:
Article 5. Stem Cell Research
125115. The policy of the State of California shall be as follows:
(a) That research involving the derivation and use of human embryonic stem cells,
human embryonic germ cells, and human adult stem cells from any source, including
somatic cell nuclear transplantation, shall be permitted and that full consideration of
the ethical and medical implications of this research be given.
(b) That research involving the derivation and use of human embryonic stem cells,
human embryonic germ cells, and human adult stem cells, including somatic cell
nuclear transplantation, shall be reviewed by an approved institutional review board.
125116. (a) A physician, surgeon, or other health care provider delivering fertility
treatment shall provide his or her patient with timely, relevant, and appropriate information to allow the individual to make an informed and voluntary choice regarding the
disposition of any human embryos remaining following the fertility treatment.
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dates 7 ' and provides state support for scientists to create new cell lines for
their research. 72 The bill, which took effect January 1, 2003, 7 3 allows
researchers in California to use federal and state funds for their research,
as long as the federal funds only support research using federally-approved
cell lines. 7 4 Using state funds, researchers may employ donated surplus
embryos or create human embryos 75 to support their research if an inde76
pendent review board has approved the project.
III.

Singapore's Stem Cell Law
"If we aspire to be a hub for the life sciences or biomedical sciences, we have got
to be doing it in a way which is internationallyacceptable. We should be morally clean and not to be seen doing things which others would not want to
do .... 77

Singapore has made rapid progress in the field of stem cell research
during the past two years. In 2001, when President Bush announced the
(b) Any individual to whom information is provided pursuant to subdivision (a) shall
be presented with the option of storing any unused embryos, donating them to another
individual, discarding the embryos, or donating the remaining embryos for research.
(c) Any individual who elects to donate embryos remaining after fertility treatments
for research shall provide written consent.
125117. (a) A person may not knowingly, for valuable consideration, purchase or sell
embryonic or cadaveric fetal tissue for research purposes pursuant to this chapter.
(b) For purposes of this section, "valuable consideration" does not include reasonable
payment for the removal, processing, disposal, preservation, quality control, storage,
transplantation, or implantation of a part.
(c) Embryonic or cadaveric fetal tissue may be donated for research purposes pursuant to this chapter.
71. State autonomy in this field may soon end, as Senator Sam Brownback has introduced Senate Bill 1899, which, if enacted into law, would ban therapeutic cloning, reproductive cloning, and the importation of products produced by such processes into the
United States with penalties of up to ten years in jail and fines of at least $1 million.
Human Cloning Prohibition Act of 2001, S.1899, 107th Cong. 2d Sess. (2002). In addition, the National Academy of Sciences released a report in 2002 recommending that the
United States create legislation to ban reproductive cloning. See COMMITTEE ON SCIENCE,
ENGINEERING, AND PUBLIC POLICY, NATIONAL RESEARCH COUNCIL, SCIENTIFIC AND MEDICAL

(2002).
72. Jim Warren, Taking Aim at Washington, CaliforniaAdopts Law Permitting Embryonic Stem Cell Research, TRANSPLANT NEWS, Sept. 27, 2002. The Bill articulates the state's
rationale for the legislation: "California's biomedical industry is a critical component of
the state's economy that provides employment in over 2,500 companies to over 225,000
Californians, pays $12.8 billion in wages and salaries, invests more than $2.1 billion in
research, and reports nearly $7.8 billion in worldwide revenue, and would be significantly diminished by limitations imposed on stem cell research." CAL. HEALTH & SAFETY
CODE §125116 (2003).
73. See Warren, supra note 72.
74. See Scientists: Stem Cell Rules Halt Progress, supra note 27 (verifying with Dr. Elias
Zerhouni, director of the NIH, that researchers in California may use both federal and
state funds).
75. Researchers can create human embryos "from any source" including somatic cell
transfer transplantation or cloning. CAL. HEALTH & SAFETY CODE § 125115(a) (2003).
76. See Warren, supra note 72.
77. See Singapore Bioethics Panel Recommends Approval of Stem Cell Research, TRANSPLANT NEWS, June 30, 2002 (quoting Lim Pin, chair of the Bioethics Advisory Committee) (emphasis added).
ASPECTS OF HUMAN REPRODUCTIVE CLONING
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federal stem cell mandates, not a single university in Singapore taught
advanced cellular biology and only one prominent researcher in Singapore,
Ariff Bongso, studied stem cells. 78 In 2002, Singapore invested in new
biomedical research facilities including a 500-acre science park, set aside
$2 billion for research-in biomedical technology until 2005, and pledged
$285 million for science scholarships. 79 Singapore is rapidly realizing the
fruits of these investments, as many major names in stem cell research have
relocated their research laboratories to the country. 8 0 Moreover, Singapore
is already charting new territory with major advances in the stem cell market, notably by producing marketable, fully human, animal-free stem cell
lines. 81 Why is Singapore, a country that a few years ago had barely
engaged in stem cell research, able to reap the benefits of a stem cell market when stem cell research in other countries is "crawling like a caterpillar?" 8 2 In short, because Singapore has tapped the potential of progressive
regulation of stem cell research.
Singapore's Bioethics Advisory Committee (BAC) was commissioned
in December 2000 to examine the ethical, legal, and social issues of
biomedical science research in Singapore. 8 3 In February 2001, the BAC
created the Human Stem Cell Research (HSR) Subcommittee to study the
ethical issues associated with human stem cell research. 8 4 In addition, the
BAC consulted with local interest groups and the public, examined interna78. See Send in the Clones, supra note 29, at 58. Bongso was the first scientist to
isolate human stem cells, but failed to patent his technique, allowing American researchers to benefit from his work. See id.
79. See Simon Montlake, Singapore's Biotech Bid City-State Laying Groundwork for
Asian Hub, INT'L HERALD TRIB., Aug. 19, 2002, available at 2002 WL 2888188.
80. Alan Coleman, the head researcher of the team that cloned the sheep Dolly,
moved his research to Singapore in 2002 to take advantage of government funding. See
Send in the Clones, supra note 29, at 58. James Tam, an American academic, was
recruited by Singapore to act as dean of the new university research faculty. See id.
Edison Liu, formerly a leading researcher at the National Cancer Institute in the U.S., is
now head of Singapore's Genome Institute. See id. Yoshiaki Ito and his research team
recently left Kyoto University to join the Institute of Molecular and Cell Biology in Singapore. See id.
81. See First Fully Human Embryonic Stem Cell Line Created in Joint Singapore-Australia Venture, TRANSPLANT NEWS, Aug. 12, 2002. Ariff Bongso, funded by ES Cell International, created a new, totally animal-free cell line that used human skin cells as feeder
cells, rather than mouse feeder cells. See id. There are plans to make animal-free cell
lines, termed the "next gold standard in stem cells," commercially available in the future.
See id.
82. See Statement of Curt 1. Civin, supra note 27, at 20.
83. See Deputy Prime Minister and Minister for Defense Dr. Tony Tan Ken Yam,
Speech at the Opening Ceremony of the Conference on "Beyond Determinism and
Reductionism: Genetic Science and the Person" (July 17, 2002) [hereinafter Dr. Tan
Speech], available at http://app10.internet.gov.sg/data/sprinter/pr/2002071702.htm).
Dr. Tan states that the purpose of the BAC was to strike a balance between the competing interests of Singapore in achieving scientific advancement and protecting its people:
"We need to allow biomedical science to develop and grow for the benefit of mankind
and the continued progress of Singapore. At the same time, we need to debate and
address the broader social and ethical issues squarely, and to put in place strong safeguards to protect the individual, public interest and the Singaporean society." See id.
84. See id.
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tional positions, and gathered written submissions on its website to understand public concerns and interests regarding stem cell research. 8 5 On
June 21, 2002, the BAC produced a comprehensive report that recommended a complete ban on human reproductive cloning and made eleven
key recommendations for regulating human stem cell research and thera86
peutic cloning.
The BAC recommended that the government permit human stem cell
research and therapeutic cloning under strict regulation.8 7 It proposed the
creation of a regulatory body to license, control, and monitor human stem
cell research in Singapore. 8 8 In order to maintain respect for the human
embryo, the guidelines permit embryonic stem cell research only when the
researcher can show that there is "strong scientific merit in and potential
medical benefit from" the proposed research. 89
The BAC recommendations also prioritize the source of stem cells
available for research: (1) existing cell lines; (2) surplus embryos; and (3)
creation of embryos. Researchers must first use existing stem cell lines
because they provide a ready source that does not require further sacrifice
of embryos. 90 In light of the limited number of existing cell lines and the
concern for possible immunological rejections, a researcher could also use
surplus embryos under the recommendations. 9 1 The BAC reasons that
among the dispositional options available to surplus embryos-perishing
or using them in research-research is an act of greater respect for the
embryo. 9 2 The BAC believes that scientists can adequately carry out
research using existing stem cell lines and surplus embryos, 93 but notes
that there may be situations in which there is no acceptable alternative but
creation of embryos. 94 In this scenario, the researcher must demonstrate
to a designated statutory body that the proposed research has strong scien95
tific merit and a large potential medical benefit.
96
The Singaporean Government accepted the BAC's recommendations
85. See id.
86. See ETHICAL,

LEGAL AND SOCIAL ISSUES IN HUMAN STEM CELL RESEARCH, REPRODUCTIVE AND THERAPEUTIC CLONING (2002) available at www.bioethics-singapore.org [herein-

after ETHICAL, LEGAL AND SOCIAL].

87. See id. at iv-vi (qualifying its recommendation by stating that human reproductive cloning should be prohibited).
88. See id. at 32-33.
89. See id. at v.
90. See id. The U.S. also permits federal funding of research using existing cell lines.
See Bush Address, supra note 1, at 955-56.
91. See ETHICAL, LEGAL, AND SOCIAL, supra note 86, at 25-26.
92. See id. at 26 (noting that while federal funding does not support the use of
surplus embryos in the United States, the NBAC supported federal funding of such
research in its report Ethical Issues in Human Stem Cell Research).
93. See id. at 26, 28.
94. See id. at 28. There is evidence that research embryos created through cloning
may offer the great benefit of deriving stem cells that are genetically compatible with the
person being treated, thereby avoiding the problems of rejection. See id.
95. See id. at 29.
96. See Chang Ai-Lien, Human Stem Cell Research Gets the Green Light, STRAITS TIMES,
July 18, 2002, at Al, available at 2002 WL 24318935.
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and appointed the Ministry of Health to establish regulations to license,
control, and monitor all human stem cell research in Singapore. 9 7 Singapore's Parliament is expected to pass the recommendations into law in
2003.98

IV.

Regulation of Stem Cell Research: A Comparison of the U.S.
Approach with Singapore's Approach

Ethical considerations feature prominently in debates about the legality of stem cell research. They shape the laws promulgated by countries
grappling to regulate stem cell research. In determining the limits of federal funding for stem cell research in the United States, the Bush administration focused almost entirely on ethical issues, incorporating its pro-life
and faith-based views into the decision. 99 In contrast, Singapore's BAC balanced ethical concerns with the potential public benefit from the research
and the costs of restricting research, to determine the scope of the country's stem cell regulations. 10 0 Thus, the BAC's approach closely resembles
a cost-benefit analysis, while the Bush approach does not take into account
non-religious considerations at all.
A comparison of these approaches, using the two fundamental ethical
questions posed by the Bush administration, illustrates the shortcomings
of the U.S. federal mandates. The two ethical questions are: (1) are
embryos human life and therefore something to protect, and (2) if the
embryos will perish anyway, should they be used in research to achieve a
greater good?
A.

Are Embryos Human Life?

The moral debate about the status of embryos revolves around the
question of whether one should treat the embryo as a living person or as a
potential life. From a strictly biological point of view, there is not a clearcut point at which human life begins, as sperm and eggs are living things
that fuse to form an embryo that potentially grows into a living person. 10 1
Many scientists support the view that after fusion of the sperm and egg, the
resulting blastocyst is not yet an embryo. 1 0 2 This is because any particular
cell in the blastocyst is just as likely to become part of the placenta, which
10 3
is discarded at birth, as it is to become part of a "potential person."
Ethics commissions in several countries, including the NIH Human
Embryo Research panel in the United States, have approved research on the
human embryo until it is fourteen days old. 10 4 Before that time, there is no
97. See id.; see also Dr. Tan Speech, supra note 81.
98. See Al-Lien, supra note 96, at A-1.
99. See, e.g., Bush Address, supra note 1, at 954-56.
100. See ETHICAL, LEGAL & SOCIAL, supra note 86.
101. See Chicken and Egg: When Does Life Begin?, ABC NEWS, Apr. 11, 2002, available
at http://www.abc.net.au/news/indepth/featureitems/cloning.htm.
102. See id.
103. See Bongso, supra note 34, at E3-9.
104. See id.
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"primitive streak," a structure that later becomes the brain and spinal cord,
providing the possibility of pain or sentience. 10 5 Thus, before fourteen
days, some scientists call a blastocyst a "pre-embryo."'10 6 Battling against
the scientific viewpoint is the more religious belief that life begins at the
moment of conception. 10 7 In this view, the use of any human embryo for
research purposes is unethical and unacceptable on the grounds that an
embryo should, at all times, be accorded full human status. 10 8
While President Bush stated that he found widespread disagreement
in his survey of the beliefs held by Americans as to whether an embryo is a
human life, 10 9 he concluded that federal funds should only be used for
existing stem cell lines where "the life and death decision has already been
made."' 1 0 President Bush thereby demonstrated his Administration's support for the view that an embryo should be treated as a human life, otherwise there would be no "life and death decision." In support of the federal
mandates, the President stated that he is obliged "to foster and encourage
respect for life in America and throughout the world." 1 1'
Singapore's BAC addressed this same ethical issue and determined
that an embryo "has a special status as a potential human being, but does
not have the same status as a living child or adult."' 12 It holds this intermediate position on the ground that an embryo has undifferentiated tissues (and so cannot feel pain) and "its form and stage of development are
not yet recognisably human." 1 3 A living child or adult, however, carries
"the investment of experience" and is self-aware; thus, their needs are more
deserving of consideration than the needs of an embryo. 1 14 The BAC
noted that one must weigh respect for the embryo against potential benefits
that may arise from research. 1 1 5 Therefore, while the BAC supports
embryonic stem cell research, it finds that this research "should take place
105. See id.
106. See id.
107. See NBAC REPORT, supra note 4, at 99 (noting that the "official" position within
Roman Catholicism opposes embryonic stem cell research). But see id. at 50 (noting
major strands of the Protestant, Jewish, and Islamic traditions "support a view of fetal
development that does not assign full moral status to the early embryo.").
108. See id. at 100.
109. See Bush Address, supra note 1, at 954. President Bush notes that one researcher
told him that "he believes this five-day-old cluster of cells is not an embryo, not yet an
individual, but a pre-embryo" that has a potential for life but is not a life because it
cannot develop on its own. See id. He notes that another person, an ethicist, stated that
"that cluster of cells is the same way you and I, and all the rest of us, started our lives"
and thus that embryos are human lives because they are the "seeds of the next generation." See id.
110. Id. at 955
111. Id.
112. ETHICAL, LEGAL AND SOCIAL, supra note 86, at iv.
113. See John Elliott, Ethical Considerations in Stem Cell Research, in ETHICAL, LEGAL
AND SOCIAL ISSUES IN HUMAN STEM CELL RESEARCH, REPRODUCTIVE AND THERAPEUTIC CLON-

A REPORT FROM THE BIOETHICS ADVISORY COMMITTEE SINGAPORE E4-3 (2002).
114. See id. It can further be argued that it would "paradoxically diminish" respect
for human life if the rights and privileges of an adult human were extended to an insentient embryo so that the two are treated as equivalents. See id.
ING:

115. See

ETHICAL, LEGAL AND SOCIAl,

supra note 86, at 25.

2004

Misapplied Ethical Considerations

only when there is very strong scientific merit in, and potential medical
1
benefit from, such research." 16
B. Should Embryonic Stem Cells Be Used for Research if They are
Going to Be Destroyed Anyway?
To address this question, one must examine the various sources of
embryonic stem cells individually, because the United States treats each
source differently.
1. Stem Cells from Aborted Fetuses
Many view the derivation of embryonic stem cells from fetal tissues,
and thus the ethical acceptability of using stem cells, as closely tied to the
ethical acceptability of abortion. Singapore has addressed this issue by
finding that elective abortions are permissible and by implementing a system to ensure that the decision to donate the tissue to research is made
independent of the decision to abort. 1 17 The United States, however, does
not permit researchers to use embryos from aborted fetuses. This position
is inconsistent with President Bush's statement that only the existing stem
cell lines as of August 9, 2001 can be used because, "the life and death
decision has already been made," in that the "life or death decision" has
also already been made for an aborted fetus. President Bush is a staunch
pro-life advocate and this decision may reflect his administration's views
on abortion. 1 18 At a pro-life rally in 2002, President Bush stated, "Our
nation should set a great goal, that unborn children should be welcome in
life and protected in law." 1 19
2.

Surplus Embryos

Surplus embryos occur when, in the process of in vitro fertilization,
doctors match sperm and egg to create embryos outside the womb and
more embryos are produced than are planted in the mother. These surplus
embryos often remain frozen in laboratories until a couple decides whether
to destroy them, allow them to be implanted in an adoptive mother, or
donate them for research purposes. President Bush acknowledged that
Americans hold varying views about whether it is ethical to allow couples
to donate surplus embryos to science. 120 He stated that some believe that
donating the embryos to science allows them to be used for a greater purpose rather than just destroying their potential. 1 2 1 Others believe it is better to destroy the embryos because experimentation does not justify
116. See id. at 25.
117. See id. at 22-23. Noting the contentious nature of the abortion issue, the BAC
concluded that this use is allowed because under the Termination of Pregnancies Act,
elective abortion is legal. See id.
118. See Yang, supra note 25 (noting that President Bush was "genuinely 'conflicted"'
about providing any support for stem cell research given his position on abortion).
119. Sylvia Moreno, Bush Message Enlivens Anti Abortion Crowd, WASH. POST, Jan. 23,
2002, at A3.
120. Bush Address, supra note 1, at 954.
121. See id.
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death. 12 2 Without stating so explicitly, the Bush administration demonstrated its support of the latter position by prohibiting researchers from
using surplus embryos.' 23 The administration concluded that using surplus embryos would cross a "fundamental moral line" of making a life or
124
death decision.
Singapore allows scientists to use surplus embryos for stem cell
research because if only existing cell lines are used, research and the potential public benefit will be limited. 1 2 5 The BAC determined that allowing
researchers to use embryos created for fertility purposes rather than
destroying them is an act of greater respect for these embryos.1 2 6 The BAC
noted that the United Kingdom, 12 7 and the NBAC report from the United
States, support this position. 1 28 To ensure that researchers do not abuse
the rules permitting use of surplus embryos, Singapore maintains strict
guidelines to obtain donor consent, 1 2 9 prohibits trade in donated
embryos, 130 and created conscientious objection guidelines to allow persons with a conscientious objection to refrain from participating in
3
research on human stem cells.1 '
3.

Creation of Embryos for Research

Scientists can create embryos solely for research purposes by a variety
of techniques, including cloning. While some people see little difference
between surplus embryos and embryos created for research, others support
the use of surplus embryos but strongly oppose the creation of embryos
solely for research. 1 3 2 The Bush administration also strongly opposes the
creation of embryos for research purposes, 13 3 especially through cloning
techniques. 1 34 The Administration found that moral concerns should be
the focus of this decision, rather than the need to find cures for
122. See id.
123. See id. at 955
124. See id.
125. See

ETHICAL, LEGAL AND SOCIAL,

supra note

86, at 26-27, para. 21-23.

126. See id. at v.
127. See id. at 26. The Nuffield Council on Bioethics analogized using surplus
embryos for stem cells to tissue donation and thus found that this did not indicate a lack
of respect for the embryos. Id.
128. See id. Although research on surplus embryos cannot be federally funded in the
United States, the NBAC in a commissioned report released in September 1999, stated a
contrary position: "Research that involves the destruction of embryos remaining after
infertility treatments is permissible when there is good reason to believe that this
destruction is necessary to develop cures for life-threatening or severely debilitating diseases when appropriate protections and oversight are in place in order to prevent abuse."
See NBAC REPORT, supra note 4, at 52.
129. See ETHICAL, LEGAL AND SOCIAL, supra note 86, at 33-34.
130. Id. at 34.
131. Id. at 34-35.
132. Id. at 27.
133. See Bush Address, supra note 1, 955.
134. See id. ("I strongly oppose human cloning, as do most Americans. We recoil at
the idea of growing human beings for spare body parts, or creating life for our
convenience.").
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diseases. 135
Singapore's BAC noted that there is a fundamental difference between
surplus embryos and embryos created solely for research. 136 It balanced
ethical concerns about the use of human embryos against the potential
benefits of research.' 3 7 One potential benefit is the capability to derive
stem cells that are immunologically compatible with the transplant recipient, which avoids possible problems of rejection. 138 Use of created human
embryos also enables scientists to determine how to reprogram adult cells
to behave like embryonic stem cells. 139 The fast pace of research development also creates a constant need for more research embryos. 140 Despite
these benefits, the BAC adopted the more conservative position that a
researcher must show compelling reasons why the creation of embryos for
research is necessary and why existing cell lines or surplus embryos are
insufficient to meet this need. 14 1 The reviewing statutory body must also
find that the proposed project has strong scientific merit and a large potential medical benefit. 142

C.

Consideration of Alternative Sources for Stem Cells

Potential alternative sources for stem cells include adult stem cells,
14 3
animal stem cells, and umbilical cord placenta. Both the United States
and Singapore 14 4 sanction federal funding for research that uses these
sources. The largest controversy arises over whether adult stem cells could
suffice as a research substitute for embryonic stem cells. Singapore noted
that while some promising research is being conducted using adult stem
cells, embryonic stem cells offer several properties, such as pluripotence, 14 5 that make them a better research medium. 14 6 The NIH similarly stated that pluripotence makes embryonic stem cells a superior
medium, because adult stem cells can only mature into the cell types of
their tissue of origin.' 4 7 The NIH found that larger numbers of embryonic
stem cells can grow in a culture, whereas adult stem cells are rare and
methods to expand their numbers have yet to be fully developed. 148 The
135. See id. ("Even the most noble ends do not justify any means.").
136. See ETHICAL, LEGAL AND SOCIAL, supra note 86, at 27.
137. See id. at v.
138. See id.
139. See id.
140. See id. The BAC also notes that in response to the fast pace of research development, the United Kingdom, under the Human Fertilisation and Embryology Act 1990,
allows the creation and use of human embryos for research purposes subject to a
license. See id. at 28. This UK regime allows embryos to be created either by IVF or
cloning techniques. See id.
141. See id. at 28-29.
142. See id. at 29.
143. See Bush Address, supra note 1, 955-56.
144. See ETHICAL, LEGAL AND SOCIAL, supra note 86, at 22-23.
145. Pluripotent means the potential to develop into any one of the many types of
tissues found in the human body. See Juengst, supra note 8, at 3180.
146. See ETHICAL, LEGAL AND SOCIAL, supra note 86, at 23-24.
147. See STEM CELL BASICS, supra note 3.
148. See id.
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Bush administration has failed to address the distinctions between adult
and embryonic stem cells. 149 President Bush conceded that though some
scientists believe embryonic stem cells have unique potential, only adult
150
stem cell research is entitled to "aggressive federal funding."
V.

The Need for Reform in U.S. Stem Cell Regulation: Failings of the
Current Approach

The Bush administration's regulation of stem cell research is in need
of reform because (1) the mandates do not reflect the views and needs of
the country but rather the administration's conservative views; and (2) the
mandates do not reflect the potential costs and benefits of the research. If
the United States had acknowledged and addressed the ethical considerations of stem cell research within the context of a cost-benefit analysis as
Singapore did, it would likely have promulgated less restrictive regulations.
The Bush administration's restrictive mandates have widespread,
debilitating effects on research. While U.S. scientists continue to struggle
with their research, Singapore's regulations enable its scientists to achieve
great advancements in biomedical science, send a message to the people of
Singapore that the government values their health and well-being, and
ensure that embryonic stem cell research continues in a highly controlled
manner.
A.

The Bush Administration's Focus on its Pro-Life and Faith-Based
Views Biased Stem Cell Mandates Toward Greater Research
Restriction

The Bush administration's approach to stem cell regulation was inappropriate. First, it removed a debate that properly belongs in the public
forum into private chambers. Second, it subsequently imposed its views,
which do not reflect the majority opinion, upon the country. The United
States, a secular country that recognizes many different religious beliefs,
commonly deals with regulatory decisions closely related to ethical debates
in a public forum, where the diverse religious and philosophical viewpoints
of Americans can be heard. Prior to the Bush administration's mandates, a
number of government agencies considered the ethics of stem cell research
by collecting opinions from the American people and referring to them in
their own recommendations. t 5 The Bush administration, more than any
149. See Bush Address, supra note 1, 954. However, Bush acknowledged that "most
scientists, at least today, believe that research on embryonic stem cells offer the most
promise because these cells have the potential to develop in all of the tissues of the
body." See id.
150. See id. at 955-56.
151. See Eric Juengst & Michael Fossel, The Ethics of Embryonic Stem Cells - Now and
Forever, Cells Without End, 284 JAMA 3180, 3182-83 (2000). In 1994, the Human
Embryo Research Panel formulated recommendations at the request of President Clinton. See id. In 1999, DHHS reinterpreted this information and the NBAC reviewed the
ethical issues of stem cell research. See generally NBAC REPORT, supra note 4 (setting
forth the NBAC's consideration of the scientific, medical, and legal issues relating to
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other, has been resolutely "faith-based." President Bush reads his Bible regularly, makes religious references in speeches, and states his reliance on
faith and God to guide his decisionmaking.' 5 2 Faith-based views and prolife beliefs strongly influenced the administration's decision to impose
restrictive regulations, and this is unfair to Americans who do not share
these belief systems. In addition, even people who do share the views of
the Bush administration wonder if the administration's strong focus on
these beliefs is a mistake. 1 5 3 Furthermore, the federal stem cell mandates
send a puzzling message to the world about the United States' interest in
biomedical advancement. Arthur Caplan, director of the Bioethics Center
at the University of Pennsylvania in Philadelphia, stated "[tihe rest of the
world thinks of us as the leader in technology. So when we sound so fear154
ful about biotechnology, people get puzzled."
1.

The Effect of the Bush Administration's Pro-Life Stance

Cadaveric stem cell tissue would provide scientists with another
source from which to derive stem cells, without making the "life or death"
55
decision that President Bush set as the dividing line for federal support.'
The Bush administration's decision not to allow research using cadaveric
tissue shortsightedly addresses the administration's anti-abortion views
and not the potential benefits to Americans. There are numerous sources
of support for this statement. First, elective abortions are legal in the
United States and have been since 1973.156 Second, a recent poll showed
that a majority of Americans support human embryonic stem cell
research, 1 5 7 and that even the majority of white Catholics polled' 58 supports the research. 1 5 9 Third, in a report commissioned by the Bush administration, the NIH sanctioned the use of cadaveric tissue for stem cell
research. 1 60

16 1
Finally, with procedural safeguards such as Singapore's,

the United States could ensure that a woman makes the decision to abort
separately from the donation decision.
2.

The Effect of the Bush Administration's Faith-Based Analysis

For any country, religious beliefs are relevant to the regulation of stem
cell research; religious leaders have been vocal in their views about the
human embryonic stem cell research). The NIH responded with its own recommendations based on this research. See id. at i-xi.
152. See Howard Fineman, Bush and God, NEWSWEEK, March 10, 2003, at 24-30.
153. See id. at 30 (discussing the public concern over President Bush's aggressive
pursuit of war with Iraq).
154. See Lisa M. Krieger, As the United States Hesitates, Other Countries Move Ahead
with Embryo Research, Mercury News, May 6, 2002, available at http://
www.siliconvalley.com/mld/siliconvalley/news/3210920.htm.
155. See Bush Address, supra note 1, at 955.
156. See Roe v. Wade, 410 U.S. 113 (1973) (legalizing abortion in all 50 states).
157. See Caldwell, supra note 66.
158. The Catholic Church's official position is pro-life. See id.
159. See id.
160. See NBAC REPORT, supra note 4, at 46-49.
161. See ETHICAL, LEGAL, AND SOCIAL, supra note 86, at 32-33.
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morality or immorality of research that uses human embryos. 1 62 In the
United States, President Bush used his own religious beliefs to support his
1 63
administration's decisions on the boundaries for stem cell research.
1 64
Stating his belief that "human life is a sacred gift from our Creator,"'
President Bush announced that the administration crafted federal stem cell
research mandates so as not to cross a "fundamental moral line.' ' 65 Singapore's approach to addressing religion in research regulation differs markedly. The BAC examined the various religious viewpoints of Singaporeans
and concluded that "Singapore is a secular state, and in the interests of
religious tolerance and social harmony specific religious convictions cannot be the basis for determining policy."' 166 For those who, because of

their beliefs, did not want to participate in research projects involving
embryonic stem cells, Singapore created the Conscientious Objection
Guidelines. 167 The Bush administration should have employed an
approach similar to Singapore's because, like Singapore, the United States
is a secular nation, and not all Americans share the same support for faithbased decisionmaking.

162. See The Stem Cell Controversy: The Debate, ABC NEWS,
at http://
abcnews.go.com/sections/politics/DailyNews/stemcells BushO10809.html; see also
Sharon M. Parker, Bringing the "Gospel to Life" to American Jurisprudence:A Religious,
Ethical, and PhilosophicalCritique of Federal Fundingfor Embryonic Stem Cell Research, 17
J. CONTEMP. HEALTH L. & POL'Y 771, 791-808 (2001) (discussing religious issues related
to embryonic stem cell research). PopeJohn Paul II stated onJuly 23, 2001: "A free and
virtuous society, which America aspires to be, must reject practices that devalue and
violate human life at any stage from conception until natural death." See id. However,
although the Catholic Church opposes stem cell research, individual Catholics have differed in their views on the subject. See NBAC REPORT, supra note 4, at 100. Some look at
the early human embryo not as an individualized human entity with the settled potential
to become a human person and thus find respectful research permissible. See id. Other
major religions have strands that could potentially support fetal research. See Send in the
Clones, supra note 29, at 58.
163. See Yang, supra note 25. In an interview with 20/20 about his regulations of
federal funding for stem cell research, President Bush stated, "I reach out to God everyday, I pray everyday, I read the Bible everyday .... I think this is the kind of decision
where it does require prayer." See id.
164. See Bush Address, supra note 1, at 955.
165. See id.
166. See Elliot, supra note 113, at E4-4.
167. See ETHICAL, LEGAL AND SOCIAL, supra note 86, at 34-35 ("With diverse views on
the ethics of human stem cell research, it is envisaged that on moral or religious
grounds, a segment of the research community and the public may not wish to be
involved in such research or in a particular manner of such research. Such objections
would be legitimate, given that Singapore is a multi-religious and pluralistic society. It is
not the remit of the BAC to challenge or reconcile disagreements held from personal
moral or religious convictions. As such, every individual should be allowed to make an
informed choice on whether to participate in such research, given his or her beliefs.
Hence, the legislative framework should provide for such a situation, in that no one
should be under a duty to participate in any such research or manner of research, which
would be authorised or permitted by the law, to which he has a conscientious
objection.").
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B. If the Bush Administration Had Engaged in a Cost-Benefit Analysis,
Like that of Singapore, the U.S. Stem Cell Mandates Would
Likely be Less Restrictive
For two decades, the executive branch of the U.S. federal government
has espoused cost-benefit balancing as its official creed for health and
safety regulations.1 68 This analysis requires both a quantitative and qualitative accounting of the effects of a regulation.1 69 The Government's rationale for using cost-benefit analysis is that regulation should promote social
welfare, 170 and that cost-benefit analysis provides an imperfect but useful
proxy for inquiry into this social welfare question. 1 7 1 Although the imperfection of cost-benefit analysis negates its applicability as a strict measure
of the value of a regulation, 172 high costs and low benefits may provide a
73
signal to the Government that something is amiss in the regulation.'
The greatest challenge for cost-benefit analysis is the incorporation of
unquantifiable costs or benefits of a regulation, such as the distributional
effects of a regulation, 174 the effect on scarce natural resources, 175 and,
importantly for stem cell research regulations, ethical considerations.
Even when not all costs and benefits are quantifiable, the process of
accounting for the consequences of a regulation is itself a useful tool to
avoid potential distortions caused by emotional evaluations of a perceived
risk. 176 The comparison in Part IV of the Bush administration's approach
to stem cell regulation with that of Singapore illustrates this point.
1.

The Bush Administration Failed to Adequately Consider the Benefits of
Stem Cell Research

Because of its focus on ethical issues raised by its pro-life and faithbased beliefs, the Bush administration failed to adequately consider the
168. See Robert W. Hahn & Cass R. Sunstein, A New Executive Order for Improving
Federal Regulation? Deeper and Wider Cost-Benefit Analysis, 150 U. PA. L. REV. 1489,
1489-90 (2002). President Reagan first issued an executive order in 1981 requiring
agencies to use cost-benefit analysis. Exec. Order No. 12,291, 3 C.F.R. 127 (1981).
Later orders, in 1985 and 1993, respectively required agencies to submit an annual regulatory plan showing that they had adhered to cost-benefit principles and to assess all
costs and benefits of regulatory alternatives. See Exec. Order No. 12,498, 3 C.F.R. 323
(1985); Exec. Order No. 12,866, 3 C.F.R. 638 (1993).
169. See Kenneth J. Arrow et al., Is There a Role for Benefit-Cost Analysis in Environmental, Health, and Safety Regulation?, 272 Sci. 221-22 (1996).
170. See Matthew D. Adler & Eric A. Posner, Rethinking Cost-Benefit Analysis, 109
YALE L.J. 165, 245-46 (1999).
171. See Hahn & Sunstein, supra note 168, at 1499.
172. See ROBERT W. HAHN & ROBERT E. LITAN, AEI-BROOKINGS JOINT CENTER FOR REGULATORY STUDIES, AN ANALYSIS OF THE THIRD GOVERNMENT REPORT ON THE BENEFITS AND

COSTS OF FEDERAL REGULATIONS tbl. 1 (2000), available at http://www.aei.brookings.org/
publications/reganalyses/reg-analysisO0001.pdf (showing that a number of recent regulations would fail a strict cost-benefit test).
173. See Hahn & Sunstein, supra note 168, at 1491.
174. See id. at 1525-27.
175. See Arrow, supra note 169, at 222.
176. See George F. Loewenstein et al., Risk as Feelings, 127 PSYCHOL. BULL. 267, 269
(2001) (stating that emotional responses can be greater than cognitive evaluations of
risk, even where people are aware that risks are small).
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potential benefits the American people may gain from stem cell research.
President Bush stated that U.S. stem cell regulations are restrictive because
the progress of stem cell research has not lived up to its initial expectations
and the research "offers both great promise and great peril." 1 77 The President's observations are not consistent with general opinion in the United
States or abroad. In a report compiled at the Bush administration's
request, the NIH concluded that stem cells from embryonic sources show
tremendous promise for treating various diseases and conditions, and it
recommended that research using both cadaveric tissue and surplus
embryos should proceed. 1 78 Countries with whom the United States is
usually on par, if not ahead of, in scientific research, such as the United
Kingdom, Singapore, Australia, Canada, and Japan, all sanction stem cell
research using surplus embryos. 1 79 With the exception of Australia, they
all allow the creation of embryos for research under strict guidelines. The
regulations of these countries are not unethical because they are less
restrictive than those of the United States. Rather, the regulations demonstrate an accounting of the medical benefits that would accrue to their citizens, the economic benefits of being a leader in biomedical research, and
the social benefits of sending a message to citizens that the government
cares about their health and well-being. The Bush administration's message is quite different. While President Bush stated his concern that
embryonic stem cell research will devalue human life, 18 0 his administration's heavy research restrictions send a message to the American people
that the U.S. government does not value their lives enough to ensure that
all avenues for developing cures and treatments are open. What will happen when some country discovers a cure for multiple sclerosis; will the
United States make that cure illegal because human embryonic stem cells
were used in its research? Will the Bush administration tell the 400,000
American Multiple Sclerosis sufferers' 8 1 that they cannot cure their disease
because it believes that the cure itself devalues human life?
2.

The Bush Administration Failed to Adequately Consider the Costs of
Restricting Stem Cell Research

The Bush administration failed to adequately consider the costs that
its restrictive mandates would impose on biomedical research in the United
States. For example, the United Kingdom's regulations are more permissive than the United States' because it considered that (1) requiring British
scientists to import embryonic stem cells would make the research more
expensive and time-consuming and could lead to obstacles in the progress
177. See Bush Address, supra note 1, at 955.
178. See NIH EXEC. SUMMARY , supra note 5, at ES-1, ES-10.

179. See, e.g., Human Fertilization and Embryology Act, 1990, c. 37 (1990) (Eng.);
Human Tissue Act, 1961, c. 54 (1961) (Eng.).
180. See Bush Address, supra note 1, at 955.
181.

See NAT'L MULTIPLE SCLEROSIS Soc'Y, About MS: Who Gets MS?, at http://

www.nationalmssociety.org.
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of potentially invaluable research;1 8 2 (2) if these obstacles existed, British
researchers would move to other countries with less restrictive attitudes
toward stem cell research;1 8 3 and (3) it was important to keep researchers
in Britain so that its patients would have access to benefits from practices
such as therapeutic cloning.1 84 The U.S. federal mandates do not protect
Americans from the harms that the United Kingdom worried about. Americans have realized these harms as (1) scientists are complaining of
research delays due to difficulty in accessing adequate cell lines; 18 5 (2)
U.S. researchers are moving to other countries with more permissive stem
cell regulations;' 8 6 and (3) Americans worry that they will not have access
to the medical treatments that stem cell research will offer. 187 These
effects of regulation have forced the United States, traditionally a leader in
biomedical research, to sacrifice major medical advances. The President
expressed his administration's belief that the sixty-four existing cell lines
would lead to "breakthrough therapies and cures."' 18 8 However, since the
President passed the stem cell mandates in August 2001, many scientists
have petitioned the President for change because the regulations have crippled the progress of their research.1 8 9 The delays in research are prompting researchers to leave the United States to work in countries with more
permissive stem cell regulations. 190 Meanwhile, countries such as Singapore, whose regulations are more permissive, are realizing advancements at
a rapid pace. 19 1 The human embryonic stem cell industry is still in its
formative stages and if the Unites States continues to restrict stem cell
research and let other countries become leaders in stem cell research, it
will relinquish control over the future direction of this industry.
If the Bush administration had adequately considered the great potential of stem cell research and the great harm that the United States would
suffer if it is unable to actively pursue this research, it likely would have
realized the need for more permissive regulations.
Conclusion
All Americans weigh the costs and benefits of their activities on a daily
basis: the choice to drive a car knowing that the exhaust contributes to
global warming; the choice to eat cereal or other packaged food, knowing
that the packaging contributes to waste and waste disposal problems; and
182. See THE ROYAL SOC'Y,STEM CELL RESEARCH AND THERAPEUTIC CLONING: AN UPDATE
4 (2000) availableat http://www.royalsoc.ac.uk/templates/statements/statementdetails.
cfm (warning that tighter regulations on embryonic stem cell research could result in
delayed benefits to British patients).
183. See id.
184. See id.
185. See Statement of Curt I. Civin, supra note 27, at 21.
186. See id. at 22.
187. See id.
188. See Bush Address, supra note 1, 955.
189. See Statement of Curt I. Civin, supra note 27, at 21.
190. See id.
191. See Send in the Clones, supra note 29, at 58.
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the choice to smoke a cigarette, knowing that the second-hand smoke may
harm the health of others. The Bush administration also makes decisions
that require balancing, such as whether or not to go to war against Iraq,
with the knowledge that soldiers will die. While an administration will
carefully consider its reasons to go to war, it does not choose not to go
because it believes it is unethical to allow Americans to benefit from the
death of soldiers. Instead, it likely engages in a thorough analysis that
weighs all relevant costs and benefits of the situation before coming to a
decision.
The Bush administration's regulation of stem cell research is too
restrictive because (1) the administration failed to put aside its pro-life and
faith-based views in favor of the views and needs of the country at large;
and (2) the administration failed to engage in a balanced analysis of the
potential costs and benefits of the research, in addition to its analysis of the
ethical considerations involved.
The Bush administration's decision to restrict federal funding of stem
cell research sends a message to the American people that it not only
believes the use of embryos for research is unethical, but that it believes the
potential benefit they will receive from the research does not outweigh this
ethical consideration. Had the Bush administration relied less on its prolife and faith-based views, and more on the scientific opinion, government
reports, and research trends in other countries, it would have realized the
enormous disadvantages that the restrictive mandates impose on the American people. If the Bush administration had balanced the costs and benefits of the research, it might have reached a different conclusion. The
administration should have more support for its mandates than faith-based
views and ethical arguments. The administration does a disservice to the
American people by passing a regulation that does not adequately consider
the costs and benefits of that regulation. The Unites States has consistently used the cost-benefit framework to make regulatory decisions, and
the administration should not have treated stem cell research differently.
Contrary to President Bush's assertion, we do not live in a brave new
world, similar to that described by Aldous Huxley, where children are born
in hatcheries with predetermined achievement potentials.1 9 2 Rather, we
live in a country with the utmost respect for human life and the utmost
appreciation for the achievement of the underdog. The essence of the stem
cell debate is whether scientists can use embryos to improve the lives of the
living-the views and lives of the American people deserve greater respect
and consideration than the Bush administration's inadequate decisionmaking process afforded them.

192. See Bush Address, supra note 1, at 955 ("We have arrived at that brave new world
that seemed so distant in 1932, when Aldous Huxley wrote about human beings created
in test tubes in what he called a 'hatchery."').

